Business
Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia
RAHWAY, N.J., October 20, 2025--Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia
About this update from Merck & Company, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":217,"url":"https://media.zenfs.com/en/business-wire.com/0f96cdab06707c16a689d0d208c57c6f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xzFIb44osqE5gli9acRM8g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQzNDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0f96cdab06707c16a689d0d208c57c6f","width":480,"height":217}},"lazy":false},{"type":"text","content":"The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects","length":127,"tagName":"p","attribs":{}},{"type":"text","content":"RAHWAY, N.J., October 20, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility at its Elkton, Virginia, site.","length":270,"tagName":"p"},{"type":"text","content":"Merck’s investment in the Center of Excellence for Pharmaceutical Manufacturing is part of a more than $70 billion investment beginning in 2025 to expand domestic manufacturing and research and development — not including any future business development transactions in R&D — to drive its long-term growth and strengthen the status of the U.S. as a global leader in biopharmaceutical innovation.","length":399,"tagName":"p"},{"type":"text","content":""Today is an important milestone for Merck, for Virginia, for manufacturing in the United States and, most importantly, for the patients we serve," said Robert M. Davis, chairman and chief executive officer, Merck. "This investment helps advance our goal of providing new, innovative treatment options for people facing serious health challenges in the U.S. and around the world."","length":400,"tagName":"p"},{"type":"text","content":"The $3 billion expansion celebrated today builds on Merck’s nearly 85-year history in Elkton, Virginia, enhancing the site with a state-of-the-art pharmaceutical Center of Excellence that will include both Active Pharmaceutical Ingredient and Drug Product investment supporting small molecule manufacturing and testing and will potentially create more than 500 full-time roles as well as 8,000 construction jobs.","length":412,"tag...